Search by Drug Name or NDC

    NDC 45802-0021-46 Betamethasone Dipropionate 0.5 mg/g Details

    Betamethasone Dipropionate 0.5 mg/g

    Betamethasone Dipropionate is a TOPICAL LOTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is BETAMETHASONE DIPROPIONATE.

    Product Information

    NDC 45802-0021
    Product ID 45802-021_b6334b53-e40c-4c23-b051-0b1ab4a3c284
    Associated GPIs 90550020004105
    GCN Sequence Number 007570
    GCN Sequence Number Description betamethasone dipropionate LOTION 0.05 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 31080
    HICL Sequence Number 003304
    HICL Sequence Number Description BETAMETHASONE DIPROPIONATE
    Brand/Generic Generic
    Proprietary Name Betamethasone Dipropionate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Betamethasone Dipropionate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form LOTION
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name BETAMETHASONE DIPROPIONATE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA072538
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0021-46 (45802002146)

    NDC Package Code 45802-021-46
    Billing NDC 45802002146
    Package 56.2 g in 1 BOTTLE, PLASTIC (45802-021-46)
    Marketing Start Date 2006-06-30
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.34587
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description BETAMETHASONE DP 0.05% LOT
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis